Brief: Innate Pharma Sa Says Sanofi to invest up to 15 million Euros In Innate Pharma
23/04/2025 06:27
April 23 (Reuters) - Innate Pharma SA IPH.PA: INNATE PHARMA REGAINS ITS RIGHTS ON CD123 TARGETING ANKET® AND ANNOUNCES SANOFI’S INTENTION TO MAKE A STRATEGIC INVESTMENT IN THE COMPANY INNATE PHARMA SA - SANOFI TO INVEST UP TO €15M IN INNATE PHARMA INNATE PHARMA SA - ELIGIBLE FOR OVER €1 BILLION IN MILESTONES Source text: ID:nBw1zXXMQa Further company coverage: IPH.PA ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Innate Pharma SA
See all newsBrief: Innate Pharma Announces Completion Of Enrollment In Phase 1 Dose Escalation Study Of Iph4502
France's Innate Pharma posts lower 2025 revenue as key contracts decline
Brief: Innate Pharma FY Operating Expenses EUR -63.013 Million
Brief: Innate Pharma Sa Says Sanofi to invest up to 15 million Euros In Innate Pharma
Brief: Innate Pharma Says Jonathan Dickinson To Be Appointed CEO And Board Member